On June 24th, Gelunhui reported that Daan Gene Co., Ltd. (002030.SZ) announced that its subsidiary Guangzhou Dari Biotechnology Co., Ltd. has recently obtained a medical device registration certificate issued by the National Medical Products Administration, specifically, the medical device name is Hepatitis C Virus Antibody (HCV) Control Product, registration certificate number: National instrument registration 20243401117. The validity period is from the date of approval to June 17, 2029. The expected use is for the critical value correction of the qualitative project for detecting hepatitis C virus antibodies. Currently, Guangzhou Dari Biotechnology Co., Ltd., a subsidiary of the company, has obtained a medical device registration certificate for "Hepatitis C Virus Antibody (HCV) Control Product". The above product is still in the market development stage, and there is uncertainty in market demand. Investors are advised to pay attention to the risks.